Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acumen Pharmaceuticals Inc
(NQ:
ABOS
)
4.070
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 29, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
4.070
Bid (Size)
4.030 (3)
Ask (Size)
4.070 (92)
Prev. Close
4.070
Today's Range
4.070 - 4.070
52wk Range
3.020 - 10.97
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Acumen Pharmaceuticals Presents in vitro Human Neuron Model for Evaluating Binding of Amyloid Beta Oligomers in Alzheimer’s Disease
March 28, 2023
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
5 Value Stocks In The Healthcare Sector
March 27, 2023
Via
Benzinga
Performance
YTD
-22.62%
-22.62%
1 Month
-22.33%
-22.33%
3 Month
-15.38%
-15.38%
6 Month
-57.52%
-57.52%
1 Year
-7.08%
-7.08%
More News
Read More
Earnings Scheduled For March 27, 2023
March 27, 2023
Via
Benzinga
Earnings Preview For Acumen Pharmaceuticals
March 24, 2023
Via
Benzinga
Acumen Pharmaceuticals's Earnings: A Preview
March 24, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 26, 2022
Via
Benzinga
Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2022 and Business Highlights
March 27, 2023
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
Acumen Pharmaceuticals to Participate in Stifel 2023 Virtual CNS Days
March 22, 2023
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2022 Financial Results on March 27, 2023
March 20, 2023
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
Acumen Pharmaceuticals to Participate in the Needham Neuroscience Forum
March 08, 2023
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
Acumen Pharmaceuticals Completes Enrollment in Phase 1 Trial of ACU193, First Monoclonal Antibody Developed to Selectively Target Toxic Aβ Oligomers in Patients with Early Alzheimer’s Disease
February 13, 2023
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors
January 04, 2023
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights
November 14, 2022
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 14, 2022
Via
Benzinga
Earnings Preview: Acumen Pharmaceuticals
November 11, 2022
Via
Benzinga
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
November 09, 2022
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
Acumen Pharmaceuticals to Report Third Quarter 2022 Financial Results on Nov. 14, 2022
November 07, 2022
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
Acumen Publishes Phase 1 Trial Design and Clinical Development Plan for ACU193, an Anti-Amyloid Beta Oligomer Antibody for Alzheimer’s Disease
November 01, 2022
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 24, 2022
Via
Benzinga
Acumen’s ACU193, an Anti-Amyloid Beta Oligomer Antibody, Granted FDA Fast Track Designation for Alzheimer's Disease
October 24, 2022
From
Acumen Pharmaceuticals, Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 12, 2022
Via
Benzinga
How Is The Market Feeling About Acumen Pharmaceuticals?
October 12, 2022
Via
Benzinga
RPM International, Lamb Weston And Some Other Big Stocks Moving Higher On Wednesday
October 05, 2022
Via
Benzinga
Bank of America To $36? Plus This Analyst Slashes PT On Citigroup
October 05, 2022
Via
Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.